Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 2/20 | 0.54 |
| ▸ | HTR2A | P28223 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HTR3A | P46098 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1923123 | 0.98 | IDO1 (0.55) | TAAR1CYP2A6CYP1A2IDO1HTR2A | |
| SCHEMBL16280268 | 0.86 | IDO1 (0.50) | TAAR1CYP2A6CYP1A2IDO1HTR2A | |
| SCHEMBL13557873 | 0.86 | TAAR1 (0.56) | TAAR1CYP2A6CYP1A2HTR2AKDM4E | |
| SCHEMBL10729588 | 0.85 | IDO1 (0.56) | IDO1ALDH1A1L3MBTL1MAOBKMT2A | |
| SCHEMBL24648946 | 0.85 | MAOA (0.54) | TAAR1CYP2A6CYP1A2IDO1HTR2A | |
| Hydrochloric Acid SCHEMBL4938620 | 0.85 | IDO1 (0.52) | TAAR1CYP2A6CYP1A2IDO1HTR2A | |
| SCHEMBL28947478 | 0.82 | TAAR1 (0.52) | TAAR1CYP2A6CYP1A2HTR2AKDM4E | |
| SCHEMBL16313190 | 0.82 | TAAR1 (0.52) | TAAR1CYP2A6CYP1A2HTR2AKDM4E | |
| SCHEMBL1718526 | 0.81 | CA12 (0.50) | TAAR1CYP2A6CYP1A2IDO1KDM4E | |
| SCHEMBL12533387 | 0.81 | IDO1 (0.48) | IDO1ALDH1A1L3MBTL1MAOBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114163776-A | Epoxy resin with pressure-bearing and leakage-stopping functions and preparation method thereof | 西南石油大学 | 2022-03-11 | — | — | CN | claimed |
| EP-0298480-A1 | Process for the optical resolution of (+)-cis or (+)-trans-permethric acid | Kuraray Co., Ltd. (JP) | 1989-01-11 | — | — | EP | claimed |
| WO-2024145483-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND METHODS OF MAKING AND USING THE SAME | HTG MOLECULAR DIAGNOSTICS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2023196975-A1 | COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | SHY THERAPEUTICS, LLC (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023153504-A1 | NUCLEIC ACID DELIVERY MATERIAL | 国立大学法人東海国立大学機構 | 2023-08-17 | — | — | WO | disclosed |
| CN-111848494-B | Guanidine compounds and uses thereof | 伊谬诺米特医疗有限公司 | 2023-08-01 | — | — | CN | disclosed |
| EP-3131877-B1 | BIGUANIDE COMPOUNDS | IMMUNOMET THERAPEUTICS INC (US) | 2023-07-19 | — | — | EP | disclosed |
| US-11690390-B2 | Taste modifying product | FIRMENICH SA (CH) | 2023-07-04 | — | — | US | disclosed |
| EP-2912954-B1 | Taste modifying product and use thereof | FIRMENICH & CIE (CH) | 2023-03-22 | — | — | EP | disclosed |
| US-20220411372-A1 | SMALL-MOLECULE INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2022-12-29 | — | — | US | disclosed |
| US-20220362396-A1 | AMINO-PYRAZINECARBOXAMIDE COMPOUNDS, CONJUGATES, AND USES THEREOF | SILVERBACK THERAPEUTICS, INC. | 2022-11-17 | — | — | US | disclosed |
| EP-1174421-A1 | 3-AMIDINOBENZENESULFONAMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES IN THE PRODUCTION THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2002-01-23 | — | — | EP | disclosed |
| EP-0326329-B1 | Quinazoline derivatives useful as insecticides. | DOW AGROSCIENCES LLC (US) | 1998-10-28 | — | — | EP | disclosed |
| US-5411963-A | Plant fungicides, miticides, insecticides | DOWELANCO (US) | 1995-05-02 | — | — | US | disclosed |
| US-5350749-A | Fungicides, insecticides and miticides | DOWELANCO (US) | 1994-09-27 | — | — | US | disclosed |
| US-5034393-A | Fungicides for plants | DOWELANCO (US) | 1991-07-23 | — | — | US | disclosed |
| EP-0414386-A1 | Condensed pyrimidine derivates | DowElanco (US) | 1991-02-27 | — | — | EP | disclosed |
| EP-0326329-A2 | Quinazoline derivatives | DowElanco (US) | 1989-08-02 | — | — | EP | disclosed |
| US-4350644-A | Isopropylbenzene derivatives | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-09-21 | — | — | US | disclosed |
| US-4328280-A | USING ISOPROPYLBENZENE COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411372-A1 | SMALL-MOLECULE INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION | BCL9, BCL9L, BCL6 | TAAR1 4879/4885CYP2A6 3531/4885CYP1A2 4372/4885 |
| US-11690390-B2 | Taste modifying product | TAS2R5, TAS2R1, TAS2R45 | TAAR1 1869/4885CYP2A6 1685/4885CYP1A2 1223/4885 |
| US-20220362396-A1 | AMINO-PYRAZINECARBOXAMIDE COMPOUNDS, CONJUGATES, AND USES THEREOF | TGFBR2, SMAD2, ACVR2A | TAAR1 903/4885CYP2A6 4230/4885CYP1A2 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.